Bill > H956

This bill mandates that various insurance policies and contracts in the Commonwealth provide coverage for Lyme disease treatment, including diagnostic testing and long-term antibiotic therapy, when deemed medically necessary by a physician based on a thorough evaluation of the patient's condition. Importantly, this coverage cannot be denied simply because the therapy might be considered unproven, experimental, or investigational. This applies to group insurance for state employees, medical expense coverage, hospital service plans, medical service agreements, and health maintenance contracts, ensuring broader access to necessary Lyme disease treatments for residents.